ARA-290
Research PhaseARA-290 (Cibinetide)
- Category
- Recovery & Healing
- Aliases
- Cibinetide, pHBSP
- Administration
- Subcutaneous injection
Documented side effects
Tier 1 · Peer-reviewed / regulatoryGenerally well-tolerated in trials
Clinical trial participants did not report significant adverse effects.
Mild injection site reactions
Minor, short-lived irritation at the injection site.